Effect of X- and Y-box deletions on the development of diabetes in H-2Eα-chain transgenic nonobese diabetic mice

Scandinavian Journal of Immunology

Volumn 63, Issue 1, 2006, Pages 17-25

  O'Shea, H ^a   Yousaf, N ^b   Altmann, D ^c   Fehervari, Z ^a   Tonks, P ^a   Hetherington, C ^d   Harach, S ^a   Bland, C ^a   Cooke, A ^a   Lund, T ^e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

H2 ANTIGEN; H2 EALPHA ANTIGEN; UNCLASSIFIED DRUG; CYCLOPHOSPHAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENE CONSTRUCT; GENE DELETION; GENE FUNCTION; GENE MUTATION; HEALTH STATUS; HOMEOBOX; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; CHEMICALLY INDUCED DISORDER; GENETIC PREDISPOSITION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MUTATION; NONOBESE DIABETIC MOUSE; SPLEEN; THYMUS;

ANIMALS; CYCLOPHOSPHAMIDE; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; H-2 ANTIGENS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; MUTATION; PROMOTER REGIONS (GENETICS); SEQUENCE DELETION; SPLEEN; THYMUS GLAND; TRANSGENES;

EID: 33644869584     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.001701.x     Document Type: Article

References (30)

1. Makino S Kunimoto K Muraoka Y Mizushima Y Katagiri K Tochino Y Breeding of a non-obese, diabetic strain of mice Jikken Dobutsu 1980 29 1 13
2. Hattori M Buse JB Jackson RA et al. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex Science 1986 231 733 5
3. Wicker LS Miller BJ Fischer PA Pressey A Peterson LB Genetic control of diabetes and insulitis in the nonobese diabetic mouse. Pedigree analysis of a diabetic H-2nod/b heterozygote J Immunol 1989 142 781 4
4. Todd JA Aitman TJ Cornall RJ et al. Genetic analysis of autoimmune type 1 diabetes mellitus in mice Nature 1991 351 542 7
5. Lund T Simpson E Cooke A Restriction fragment length polymorphisms in the major histocompatibility complex of the non-obese diabetic mouse J Autoimmun 1990 3 289 98
6. Acha-Orbea H McDevitt HO The first external domain of the nonobese diabetic mouse class II, I-A beta chain is unique Proc Natl Acad Sci USA 1987 84 2435 9
7. Slattery RM Kjer-Nielsen L Allison J Charlton B Mandel TE Miller JF Prevention of diabetes in non-obese diabetic I-Ak transgenic mice Nature 1990 345 724 6
8. Miyazaki T Uno M Uehira M et al. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice Nature 1990 345 722 4
9. Lund T O'Reilly L Hutchings P et al. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain Nature 1990 345 727 9
10. Singer SM Tisch R Yang XD McDevitt HO An Abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells Proc Natl Acad Sci USA 1993 90 9566 70
11. Quartey-Papafio R Lund T Chandler P et al. Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus J Immunol 1995 154 5567 75
12. Nishimoto H Kikutani H Yamamura K Kishimoto T Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice Nature 1987 328 432 4
13. g7 molecule J Immunol 2001 167 4104 14
14. Deng H Apple R Clare-Salzler M et al. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease J Exp Med 1993 178 1675 80
15. Schmidt D Verdaguer J Averill N Santamaria P A mechanism for the major histocompatibility complex-linked resistance to autoimmunity J Exp Med 1997 186 1059 75
16. Hanson MS Cetkovic-Cvrlje M Ramiya VK et al. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection J Immunol 1996 157 1279 87
17. Brenden N Bohme J Disease-protected major histocompatibility complex Ea-transgenic non-obese diabetic (NOD) mice show interleukin-4 production not seen in susceptible Ea-transgenic and non-transgenic NOD mice Immunology 1998 95 1 7
18. Johnson EA Silveira P Chapman HD Leiter EH Serreze DV Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: additive, but unequal, involvement of multiple APC subtypes J Immunol 2001 167 2404 10
19. Parish NM Chandler P Quartey-Papafio R Simpson E Cooke A The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes Eur J Immunol 1993 23 2667 75
20. Dorn A Durand B Marfing C Le Meur M Benoist C Mathis D Conserved major histocompatibility complex class II boxes - X and Y - are transcriptional control elements and specifically bind nuclear proteins Proc Natl Acad Sci USA 1987 84 6249 53
21. Bohme J Schuhbaur B Kanagawa O Benoist C Mathis D MHC-linked protection from diabetes dissociated from clonal deletion of T cells Science 1990 249 293 5
22. Gonzalez A Katz JD Mattei MG Kikutani H Benoist C Mathis D Genetic control of diabetes progression Immunity 1997 7 873 83
23. Hyldig-Nielsen JJ Schenning L Hammerling U et al. The complete nucleotide sequence of the I-E alpha d immune response gene Nucleic Acids Res 1983 11 5055 71
24. Feinberg AP Vogelstein B A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity Anal Biochem 1983 132 6 13
25. O'Reilly LA Hutchings PR Crocker PR et al. Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression Eur J Immunol 1991 21 1171 80
26. Harada M Immune disturbance and pathogenesis of non-obese diabetes-prone (NOD) mice Exp Clin Endocrinol 1987 89 251 8
27. van Ewijk W Ron Y Monaco J et al. Compartmentalization of MHC class II gene expression in transgenic mice Cell 1988 53 357 70
28. Brenden N Bohme J Disease-protected major histocompatibility complex Ea-transgenic non-obese diabetic (NOD) mice show interleukin-4 production not seen in susceptible Ea-transgenic and non-transgenic mice Immunology 1998 95 1 7
29. Brenden N Rietz C Bohme J E Expression is needed on both bone marrow derived cells and thymic epithelium to increase IL-4 production and achieve protection in NOD bone marrow chimeras Cytokine 1999 11 766 72
30. Rietz C Pilstrom B Brenden N Bohme J Minute defects in the expression of MHC E molecules lead to impaired protection from autoimmunity in NOD mice Scand J Immunol 1999 50 405 10